Investigators compared prostatic artery embolization against a combination of an alpha blocker and 5-alpha reductase inhibitor for BPH. Investigators tested the efficacy of prostatic artery embolization (PAE) vs drug therapy in men with benign prostatic hyperplasia (BPH).